Literature DB >> 10945226

The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

L Salter-Cid1, P A Peterson, Y Yang.   

Abstract

HFE is a non-classical major histocompatibility complex class I molecule that complexes with a beta2-microglobulin. A functional link between HFE and iron metabolism has been established by the discovery of a physical association between HFE and the transferrin receptor. By inhibiting transferrin receptor internalization, HFE functions as a negative modulator of transferrin receptor function. In addition, HFE appears to be an iron sensor that directly or indirectly communicates the body's iron status to T cells, which then use cytokines as feedback modulators to achieve iron homeostasis. A working model for the feedback regulatory mechanism between iron metabolism and immune function is proposed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10945226     DOI: 10.1385/IR:22:1:43

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  123 in total

1.  Haemochromatosis and HLA-H.

Authors:  E C Jazwinska; L M Cullen; F Busfield; W R Pyper; S I Webb; L W Powell; C P Morris; T P Walsh
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

2.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

Review 3.  Molecular insights into mechanisms of iron transport.

Authors:  N C Andrews; M D Fleming; J E Levy
Journal:  Curr Opin Hematol       Date:  1999-03       Impact factor: 3.284

4.  The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor.

Authors:  J A Lebrón; A P West; P J Bjorkman
Journal:  J Mol Biol       Date:  1999-11-19       Impact factor: 5.469

5.  Identification of serine 24 as the unique site on the transferrin receptor phosphorylated by protein kinase C.

Authors:  R J Davis; G L Johnson; D J Kelleher; J K Anderson; J E Mole; M P Czech
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

6.  Interferon gamma response region in the promoter of the human DPA gene.

Authors:  Z Yang; M Sugawara; P D Ponath; L Wessendorf; J Banerji; Y Li; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1.

Authors:  R E Fleming; M C Migas; X Zhou; J Jiang; R S Britton; E M Brunt; S Tomatsu; A Waheed; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

8.  Stress proteins are immune targets in leprosy and tuberculosis.

Authors:  D Young; R Lathigra; R Hendrix; D Sweetser; R A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105.

Authors:  R Raha-Chowdhury; D J Bowen; C Stone; J J Pointon; J D Terwilliger; J D Shearman; K J Robson; A Bomford; M Worwood
Journal:  Hum Mol Genet       Date:  1995-10       Impact factor: 6.150

10.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

View more
  4 in total

1.  Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis.

Authors:  S V Ben-Arieh; B Zimerman; N I Smorodinsky; M Yaacubovicz; C Schechter; I Bacik; J Gibbs; J R Bennink; J W Yewdell; J E Coligan; H Firat; F Lemonnier; R Ehrlich
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  HFE inhibits type I IFNs signaling by targeting the SQSTM1-mediated MAVS autophagic degradation.

Authors:  Juan Liu; Xiaopeng Wu; Hailong Wang; Jiayu Wei; Qian Wu; Xingbo Wang; Yan Yan; Jun Cui; Junxia Min; Fudi Wang; Jiyong Zhou
Journal:  Autophagy       Date:  2020-08-18       Impact factor: 13.391

Review 3.  β2-Microglobulin-mediated signaling as a target for cancer therapy.

Authors:  Takeo Nomura; Wen-Chin Huang; Haiyen E Zhau; Sajni Josson; Hiromitsu Mimata; Leland W K Chung
Journal:  Anticancer Agents Med Chem       Date:  2014-03       Impact factor: 2.505

Review 4.  Iron Metabolism in Cancer Progression.

Authors:  Stefania Forciniti; Luana Greco; Fabio Grizzi; Alberto Malesci; Luigi Laghi
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.